Introduction

46
A regimen of priming with recombinant DNA and boosting with a viral vector has been shown to 47 elicit strong T-cell immune responses (1-3) and is, thus, becoming one of the most prevalent vaccine 48 strategies (4). Several regimens have been widely adopted, including the DNA prime-vaccinia vector 
56
Several attributes of CD8 + T cells contribute to the containment of viral replication in vivo, and 57 these include the magnitude of the response, the diversity of the TCR, and the functional avidity. Among 58 those factors, the functional avidity, which is also referred to as antigen sensitivity (8), is one of the most 59 critical properties for the determination of CD8 + T cell efficacy (9, 10). In principle, the strength of the of the functional avidity in vivo.
82
Materials and Methods
83
DNA vaccines and recombination vaccinia vaccines. influx, we performed the staining process on ice to minimize this effect (27).
157
Statistical analysis. Statistical analysis was performed by t test using the SPSS16.0 software.
158
Results
159
Increased antigen-specific memory CD8 + T cells with enhanced functional avidity following VACV 160 boost. To evaluate the effect of VACV boost on antigen-specific CD8 + T cell responses that were primed 161 by DNA vaccine, we immunized BALB/c mice with vaccines expressing HIV-Gag (Fig. 1A) . Three following DNA priming.
175
We then compared the functional avidity induced by different immunization regimens. We measured 176 the peptide concentration required to generate 50% of the maximum IFN-γ SFUs using ELISpot assay.
177
The VACV boost increased the antigen sensitivity of the responding CD8 + T cells (7.60×10 -8 ±1.25×10 -8 178 mg/ml) approximately 100-fold compared to that of DNA prime alone (6.39×10 -6 ±2.01×10 -6 mg/ml) and 179 10-fold compared to that of DNA boost (7.27×10 -7
±9.88×10 -8 mg/ml), and these findings were consistent 180 with previous reports (16, 17) ( Fig. 1E, G) . Similar patterns were also observed for a sub-dominant 181 epitope (Gag64) of HIV-Gag (Fig. 1F, G antibodies at lower concentrations from 10 -5 μg/ml to 10 -4 μg/ml, whereas those from animals that 195 received DNA prime alone or a DNA boost responded to 10 -4 μg/ml to 10 -2 μg/ml anti-CD3 antibodies
196
( Fig. 1H, right panel) . Thus, epitope-specific CD8 + T cells induced by VACV boost were 10-100 times complex, which is the physical determinant of functional avidity of antigen-specific CD8 + T cells using the tetramer decay assay (9, 29). As shown in Fig.2A mice and compared the functional avidity between the OVA-specific CD8 + T cells from animals receiving the DNA boost and those receiving the VACV boost (Fig. 3A) . The differences in both the 228 magnitude (Fig. 3B) and the functional avidity (Fig. 3C, D and E and the order of the avidities among the groups was not altered, although immuno-affinity magnet 258 separation modestly reduced the overall avidity (Fig. 4A) . Second, we mixed purified CD8 + T cells with not increase the avidity of CD8 + T cells (Fig. 4B) (Fig. 4C) . Thus, based on these findings, the functional avidity of CD8 + T cells is unlikely to be affected 266 by the cytokine milieu provided by VACV-sensitized APCs in the ELISpot assay.
267
We also determined whether other parameters, such as the cytokines produced by CD4 + T helper we boosted mice with a mixture of DNA vaccine and mock VACV. Unexpectedly, the additional 280 introduction of mock VACV into the DNA boost failed to increase the magnitude (Fig. 4D) or the 281 functional avidity (Fig. 4E and F and then determined the functional avidity of CD8 + T cells (Fig. 5A) . The MyD88 -/-mice displayed a 291 significant reduction in both the magnitude and the functional avidity of antigen-specific CD8 + T cells 
MyD88
-/-mice ( Fig. 5C and D) , demonstrating that the MyD88 pathway is essential for inducing 296 high-avidity memory CD8 + cells with the VACV boost.
297
The fact that VACV did not boost CD8+ T cells with high functional avidity in MyD88 -/-mice 298 suggests that loss of MyD88 affects APC response to VACV infection. Therefore, we then examined 299 inflammatory cytokine production and DC maturation after MyD88 -/-splenocytes were exposed to 300 VACV infection. VACV induced high levels of inflammatory cytokines in splenocytes from WT mice 301 (Fig. 6A) . In contrast, the production of cytokines was significantly reduced in MyD88 -/-cells (Fig. 6B) , 302 whereas MyD88 -/-DCs matured normally following in vitro exposure to VACV (Fig. 6C) . In agreement 
MyD88
-/-mice.
306
To determine whether the reduction in inflammatory cytokine production in MyD88 -/-mice accounts 307 for the decrease in the observed functional avidity of the CD8 + T cells, we adoptively transferred OT-I CD8 + T cells, which express MyD88 and recognize the OVA epitope, into MyD88 -/-recipients (Fig. 7A) 
309
and then immunized the mice with OVA-expressing DNA followed by either a DNA or a VACV boost.
310
Interestingly, the VACV boost restored the ability of these cells to boost high-avidity OVA-specific CD8 +
311
T cells, indicating intrinsic MyD88 signaling in CD8 + T cells dictates the avidity-shaping process 312 following VACV-boost (Fig. 7B, C and D) . transferred to WT mice, which were then boosted by DNA vaccine or VACV vaccine (Fig. 8A) , both the 317 magnitude ( Fig. 8B ) and the functional avidity ( Fig. 8C and D) of the OVA-specific CD8 + T cells
318
induced by VACV-boost were significantly impaired, whereas no significant impact was observed on 319 these parameters following DNA boost, demonstrating that the functional avidity of CD8 + T cells is 320 largely determined by the intrinsic MyD88 pathway in CD8 + T cells.
321
Overall, these data demonstrate that the high functional avidity of memory CD8 + T cells boosted by
322
VACV is independent of the inflammatory milieu and that the intrinsic MyD88-mediated pathway in 323 CD8 + T cells is essential in shaping the functional avidity in response to VACV boost.
324
Discussion
325
Understanding how the components of a vaccine regimen shape the properties of T cell responses is 
361
Importantly, our data reveal that the functional avidity of memory CD8 + T cells may be sequentially 362 tuned by a DNA vaccine followed by a VACV vaccine, and thus, these studies provide evidence that this and DNA vaccine were administered to concurrently induce the inflammatory milieu with a DNA boost.
564
The magnitude (D) and the functional avidity (E and F) were measured. These experiments are 565 performed as described in Figure 1 and the dominant epitope, Gag49, is employed for stimulation. Data 
